Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016-2022 review data.

In 2020, China had 4.57 million new cancer cases, accounting for 23.7% of the world’s total, with the number of new cancer cases far exceeding that of the rest of the world, and the prevalence of immune diseases also showed an increasing trend ( Xia et al., 2022 ; Chen et al., 2023 ).

also in 63,971 other papers